1. Home
  2. ETJ vs CERS Comparison

ETJ vs CERS Comparison

Compare ETJ & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

ETJ

Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

HOLD

Current Price

$8.46

Market Cap

563.3M

Sector

Finance

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.91

Market Cap

585.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETJ
CERS
Founded
N/A
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
EDP Services
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
563.3M
585.1M
IPO Year
2007
1996

Fundamental Metrics

Financial Performance
Metric
ETJ
CERS
Price
$8.46
$2.91
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
133.8K
2.9M
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
N/A
$51,326,000.00
Revenue This Year
N/A
$19.95
Revenue Next Year
N/A
$8.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.68
52 Week Low
$7.88
$1.15
52 Week High
$9.12
$3.47

Technical Indicators

Market Signals
Indicator
ETJ
CERS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
ETJ
CERS

About ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Risk-Managed Diversified Equity Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income and gains, with a secondary objective of capital appreciation. The group invests in various sectors such as financials, healthcare, consumer discretionary, consumer staples, industrials, energy, utilities, telecommunication services, and materials. Under normal market conditions, the Fund's investment program consists of majorly owning a diversified portfolio of common stocks and employing a variety of options strategies.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Share on Social Networks: